Gruppo di Studio sulla Leishmaniosi Canina
CLWG consider necessary the publication of scientific studies in peer-reviewed international journals before to evaluate the efficacy of CaniLeish® vaccine.
CLWG consider mandatory the publication of additional scientific studies in peer-reviewed international journals before to evaluate the efficacy of Leisguard® drug.
Second semester 2011
In the second semester of 2011 the autumnal meeting of CLWG was held in Rome (November 4th) where the activity plans for 2012 has been outlined. In this occasion the resignation letter from Dr. Alberto Crotti was discussed. Dr. Crotti was the referent of the CLWG for oftalmology and his specific activity considering his competence was mainly directed toward to the relationship between leishmaniosis and ocular diseases. Members of CLWG, expressing regret for Dr. Crotti decision accepted his resignation highlighting his professional activity that was of great help both for the scientific side and the link with SCIVAC-EV. The competence of Dr. Crotti will not covered inside the CLWG. Whether in the future, consultation about this scientific field Dr. Crotti will be contacted primarily.
Members of CLWG finalized also the discussion of the research project whose title is: “Evaluation of clinical and laboratory remission times in dogs affected by proteinuria associated with leishmanioisis that underwent to different therapeutic-management protocols”.
In the same meeting the scientific background that is based the action of domperidone (Leisguard®, Esteve) in the control of canine leishmaniosis was evaluated. The CLWG has not yet given his opinion about the efficacy of domperidone, as the scientific background supporting this drug is not yet largely demonstrated from publication of a series of papers in peer-reviewed international journals.
Finally, a draft of guidelines about prognosis and monitoring of canine leishmaniosis was discussed. In addition, the CLWG and Hill’s Pet Nutrition agreement for the next year 2012 was settled. Hill’s Pet Nutrition was the company that constantly supported the several scientific activities of CLWG.
Second four-month period of 2012
The program carried out in this period has been focused mainly into the activities of CLWG inside the 73rd Multi-hall International Congress SCIVAC held in Rimini from June 8th to 10th. Indeed, in that event the entire afternoon of Saturday June 9th has been devoted to the presentations on canine leishmaniasis organized by CLWG. The session chaired by Prof. Lubas was arranged in the following schedule for the main speeches:
Dr. Fondati presented a speech entitled “Follow-up, prognosis and monitoring of the dog affected by leishmaniasis”
Dr. Zatelli presented a speech entitled “Pathogeneses and management of proteinuria in the dog affected by leishmaniasis”.
First four-month 2012
In the meeting of March 2nd 2012 in Rome the detailed activity of 2012 was organized.
In the occasion, the CLWG confirmed that are still lacking evidence of the efficacy of domperidone in canine leishmaniosis due to a reduced number of papers to support the action of this drug. In addition, the CLWG stated the same questioning for the action of the vaccine that will be launched in the Italian market from Virbac (CaniLeish®). The CLWG regret that the scientific documentation supporting the vaccine introduction was available only after the product was already disclosed to the common media directed to the consumers besides dog’s owner.
In order to share the news concerning the C.L.W.G. activity, a web site has been arranged during 2006 (www.gruppoleishmania.org) in cooperation with S.C.I.V.A.C., where Dr. Stefano Zigiotto is responsible of the graphics, Prof. George Lubas is in charge for the contents of the web pages and finally dr. Enrico Febbo is responsible of the technical and managing site aspects.
The C.L.W.G. web site display: Objectives & Aims, Group Delegates, Study Subgroups, Photogallery and Web pages and the latest activities.